Novo Nordisk Q3 sales beat, adjusted operating profit up 27% at CER; EPS misses

Novo Nordisk reported Q3 sales of DKK 79,195M, beating the DKK 73.83B estimate, with sales up 6% YoY (+4% CER). Adjusted operating profit was DKK 31.7B, up 27% at CER, while EPS of DKK 3.79 missed the DKK 5.09 estimate.

Detected & updated continuously · Source: Nebula